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Supramolecularly Assisted Synthesis of Chiral Tripodal Imidazolium Compounds
Adriana Valls, Belén Altava,* M. Isabel Burguete, Jorge Escorihuela, Vicente Martí-Centelles, 
Santiago V. Luis*
Abstract A strong preference for the formation of tripodal systems over the related monotopic and ditopic compounds 
is observed for the reaction between tris(halomethyl)benzenes and imidazoles derived from aminoacids and containing an 
amide fragment. This preference allows the formation of the tripodal derivative as the very major product even when an 
equimolar mixture of the tris(halomethyl)benzene and the imidazole is reacted (1:1 ratio instead of the stoichimetric 1:3 
ratio). The reactions were monitored using 1H NMR spectroscopy and ESI mass spectrometry and kinetically characterized. 
Computational studies were also performed in order to rationalize the observed preference of the tri-substituted product. 
Results reveal the existence of well defined supramolecular interaction between the imidazolium groups and the reacting 
imidazoles that facilitate the formation of the multitopic systems once the first imidazolium group is formed. The analysis 
of the different structural components shows that the presence of the amide group from the aminoacid moiety is the key 
structural requirement for such supramolecular assistance to take place. The preorganization of the supramolecular 
intermediates formed through hydrogen bonding interactions involving amide-NH fragments in imidazoles and bromide 
anions in imidazolium groups, seems to be also present at the corresponding TSs, decreasing the associated energy 
barriers.
Introduction
In Nature, biomolecules are synthetized very efficiently, 
frequently triggered by external stimuli, through processes 
encompassing the appropriate supramolecular preorganization 
of the involved components. This is illustrated by enzymes 
displaying a high supramolecular preorganization.1 Their 
catalytic activities depend on the presence in the active site of 
functional groups, often belonging to amino acids situated far 
away in the peptidic sequence, located at the right distances 
and orientations and facilitating the proper preorganization of 
the substrates for the corresponding reaction.2,3
A suitable preorganization of the substrates assisted by 
supramolecular interactions can also be important in abiotic 
systems, particularly for synthetizing macrocyclic structures.4 
In this case, the approaching of the two reactive ends is 
facilitated by the folding of the open-chain intermediate 
through hydrogen-bonding, conformational or configurational 
factors or by the use of templates.5 For non-cyclic compounds, 
the formation of cyclic or chelate hydrogen bonds in close 
proximity of the target covalent bond can promote the desired 
reaction, facilitating the approach of the reactive elements.6 
Thus, the development of structures able to control a 
hierarchically ordered synthesis is an important and 
challenging target. 
Considerable efforts have been made in developing self-
replicating systems.7 In a model self-replicating system, the 
final molecule is able to selectively recognize the component 
fragments and preorganize them in the correct location as to 
promote the synthesis of a new identical molecule in a self-
catalytic process.8,9 If several interacting replicators are 
combined, then complex behaviours can occur as the network 
of cross and autocatalytic reactions increases in size.10,11
In this regard, the synthesis of polytopic receptors can benefit 
from a proper recognition by the monotopic intermediate of 
one of the components, favouring the synthesis of the ditopic 
system. The recognition of this component by the ditopic 
intermediate would favour the preparation of the tritopic 
compound and so on, eventually leading to polytopic systems 
even in the presence of a limited amount of the component 
being recognized. In this context, polytopic supramolecular 
imidazolium receptors are of current relevance taking into 
account their properties as receptors and transporters,12,13 
with tripodal imidazolium compounds providing flexible but 
selective 3D environments for anion recognition.14 Thus, based 
on previous results of our group,15 tripodal compounds 
displaying the general structure I (Figure 1) represented an 
interesting target, combining a well-defined 3D cavity with 
hydrogen bonding potential (amide and imidazolium moieties) 
with hydrophobic and aromatic regions playing essential roles 
in supramolecular recognition.16 They integrate the 
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supramolecular features of imidazolium compounds and those 
of amphiphilic pseudopeptides.17 The synthetic approach is 
straightforward, involving the reaction of three equivalents of 
the corresponding imidazole with a tris(halomethyl)benzene. 
However, the accumulation of charge in the periphery of the 
aromatic fragments could hamper the introduction of the 
second and the third charged fragment. Rather surprisingly, 
preliminary experiments showed that even working with a 
defect of the imidazole (e.g. equimolar mixtures) the tripodal 
imidazolium compound was always preferentially obtained 
over the related mono- and ditopic molecules.



































































Figure 1 Polytopic supramolecular receptors based on imidazolium and related 
systems: a) citrate receptor, ref. 18b; b) halide recognition, ref. 14a; c) citrate 
and malate recognition, ref. 15a; d) anion recognition involving halogen-bonding 
instead of hydrogen bonding, ref. 14f; e) transmembrane chloride transport and 
CSA for dicarboxylic acids, ref. 15b; f) tripodal receptors in this work.
In the light of these initial results, this process has been 
studied in detail to properly understand the specific 
supramolecular effects favouring the formation of the tripodal 
imidazolium species and the influence of the different 
structural elements. The combination of experimental results 
and computational studies has been essential for 
understanding the effects observed.
Results and Discussion
As shown in Figure 1, the general tripodal structure I contains 
three elements of diversity: the central aromatic core, the side 
chain of the amino acid used for the preparation of the 
imidazole ring and the length of the aliphatic chain attached to 
the amino acid moiety through an amide bond. The final 
synthetic step involves a [1+3] SN2 process between a 
tris(halomethyl)benzene and an amino acid based imidazole 
(Scheme 1). Tris(halomethyl)benzenes are standard alkylating 
agents used in the synthesis of different tripodal receptors 
including imidazolium salts and pseudopeptic cages,18,19 and 
the synthesis of the considered amino acid based imidazoles 
































1A-2A R': (CH2)11CH3, X: Br, Y: Br, n=1
1A2- 2A2 R': (CH2)11CH3, X: , Y: Br, n=2
1A3- 2A3 R': (CH2)11CH3, X: , Y: , n=3
1B-2B R': CH3, X: Br, Y: Br, n=1
1B2-2B2 R': CH3, X: , Y: Br, n=2
1B3-2B3 R': CH3, X: , Y: , n=3
N N R'
1C-2C R': (CH2)11CH3, X: Br, Y: Br, n=1
1C2-2C2 R': (CH2)11CH3, X: , Y: Br, n=2
1C3-2C3 R': (CH2)11CH3, X: , Y: , n=3
1D-2D R': CH3, X: Br, Y: Br, n=1
1D2-2D2 R': CH3, X: , Y: Br, n=2






























Scheme 1 Synthetic approach for the preparation of polytopic imidazolium compounds from the reaction between different imidazoles (A-C) and 1,3,5-
tris(bromomethyl)benzene derivatives (1, 2). The structure of each polyimidazolium compounds is denoted by three digits, the first one is a number related to the 
aromatic component (1 or 2), the second one indicates the imidazole used (A-C) and the third one, included as a subindex, defines the monoimidazolium (NX1), 
bisimidazolium (NX2) or tris(imidazolium) (NX3) structure.
Initial experiments involving tris(bromomethyl)benzene 1 and 
the imidazole obtained from valine and containing a dodecyl 
aliphatic tail (C) (Scheme 1) revealed that the preparation of 
the corresponding tripodal trisimidazolium compound 1C3 took 
place very efficiently. Even when a defect of imidazole was 
used (equimolar 1:C ratio) the tripodal derivative 1C3 was the 
major species formed, while the monotopic (1C) and the 
ditopic (1C2) imidazolium salts were only obtained as 
minoritary side products (1C3: 73%, 1C2: 12% and 1C: 5%).
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In order to analyse the generality of this process and its origin, 
the preparation of a family of imidazolium compounds, as 
shown in Scheme 1, was considered. To simplify this analysis, 
the amino acid component was fixed to be L-valine, while the 
alkyl chain attached to the amide nitrogen atom was either 
dodecyl (long aliphatic tail, imidazole C) or methyl (short 
aliphatic tail, imidazole D). Finally the alkylating agents 
selected were 1,3,5-tris(bromomethyl)benzene (1) and its 
2,4,6-trimethyl derivative (2), previously used for the synthesis 
of tris(imidazolium) derivatives.18,19 Commercially available N-
dodecyl (A) and N-methyl (B) imidazoles were also studied as 
nucleophiles to provide proper comparison models lacking the 
amino acid based fragment.
1H NMR and ESI-MS experiments. Initial kinetic experiments 
were carried out in CDCl3 by 
1H NMR. To ensure that 
aggregation processes did not interfere, it was checked that 
these imidazoles do not aggregate in this solvent in the 1 to 60 
mM range (ESI, Fig S1 for imidazoles A and C). Thus, the 
imidazole concentration was fixed in all experiments to ca. 15 
mM in CDCl3 and the reactions were carried out in an NMR 
tube. The temperature was maintained constant at 25ºC and 
dioxane (0.17 mM) was used as the internal standard. 1H NMR 
spectra were obtained directly from these reaction tubes and 
the same reaction crudes were also analysed by ESI-MS. The 
reactions were monitored for up to ca. 700 h. Different 
tris(halomethyl)arene : imidazole molar ratios (ca. 1:3, 1:2 and 
1:1) were assayed. Although some of the signals of interest 
could overlap at specific reaction times, 1H NMR spectra 
allowed determining the concentration of the different species 
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Figure 2 Partial 1H NMR (400 MHz, CDCl3) spectra obtained at different time 
intervals for the reaction of tris(bromomethyl)benzene 1 (13.8 mM) with 
imidazole C (13.8 mM) at 25ºC. The region around 10 ppm corresponding to the 
presence of C2-H signals of the imidazolium rings has been expanded for the 
spectrum after 6 h of reaction.
Figure 2 shows the 1H NMR spectra for the process leading to 
1C3 when an equimolar mixture of the aromatic compound 1 
and imidazole C was used. The signal corresponding to the C2-
H proton of the imidazolium ring in 1C3 was observed initially 
at ca. 10.03 ppm, while the signals for the mono- and di-
substituted products appeared at 10.22 and 10.20 ppm 
respectively (see the expanded region after 6 h of reaction). 
These chemical shifts, and others used in this study, agreed 
well with those obtained for the pure isolated 1C3, and for the 
model compounds 3 and 4 that had been prepared previously 
(Figure 3; ESI, Fig S2).15a The formation of 1C3 could also be 
followed through the appearance of other characteristic 
signals like those for the amide NH and the proton at the 
stereogenic carbon atom (C*-H) initially at 8.22 and 5.08 ppm 
respectively. The signals originally at 7.78, 6.14 and 4.21 ppm, 
corresponding to the imidazole C2-H, amide NH and the C*-H 
of the starting imidazole C could be used to monitor its 
disappearance. Figure 4 gathers the kinetic profiles obtained 
for this reaction using these signals. Data presented in Figure 4 
(top) for the equimolar mixture of 1 and C show clearly how 
the formation of the tripodal compound 1C3 is significantly 
favoured over that of the mono- and di-substituted species 1C 
and 1C2. After 77 h, the conversion of the starting imidazole C 
raised to ca. 65% with 46 % of these units incorporated into 
1C3, 9 % of them into 1C2 and only 9 % into 1C. After this time, 
the concentration of 1C3 continued increasing but not those of 
1C2 and 1C. After 360 h, imidazole conversion reached ca. 90 
%, with more than 72 % of the consumed imidazole groups 
incorporated into 1C3. The inset in Figure 4 reveals the 
existence of an apparent induction period for the formation of 
the bis- and tris-imidazolium derivatives 1C2 and 1C3 (ca. 3 and 
4 h respectively), but not for 1C, which has been often 
associated to processes involving autocatalytic steps or related 
processes.7-10 Similar results were obtained when the 1:C ratio 
was changed to 1:2.1 or 1:2.8 (ESI, Figure S3) with 1C3 being 


















































Figure 4. Variation with time of the concentration of the different species for an 
equimolar mixture (13.8 mM) of 1 and C as measured following the C2-H proton 
signals of the imidazolium compounds (green 1C3, yellow 1C2, grey 1C) and those 
for the C*-H (blue) signal for C; the inset displays the formation of imidazolium 
species at initial times. Reaction carried out in CDCl3 at 25ºC.
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ESI-MS also allowed monitoring the reaction, identifying 
charged species associated to the starting imidazole building 
block C and to the tri-, di- and mono-imidazolium derivatives 
(1C3, 1C2 and 1C). Thus, for the reaction between 1,3,5-
tris(bromomethyl) benzene 1 and the imidazole C in an 
equimolar ratio, after 48 h, the ESI-MS in positive ion mode 
(Figure 5) contained a peak at m/z 612.4 for the 
monosubstituted compound [1C-Br]+ (100 % relative intensity) 
and a second minor peak at 434.6 (20 %) associated to the 
bisimidazolium compound [1C2-2Br]
2+. Species corresponding 
to the trisimidazolium product appeared at 374.6 and 602.0 
associated to [1C3-3Br]
3+ (75 %) and [1C3-2Br]
2+ (80 %, this 
peak can also contain contributions from [1C2-2Br+C]
2+) and at 





Moreover at 336.3 (50 %) and 671.8 (16 %) appeared peaks 
associated to [C+H]+ and [C+C+H]+ species from unreacted 
imidazole. After 697 h the peak at 612.4 for [1C-Br]+ decreased 
significantly (20 %) while the peak at 434.6 associated to [1C2-
2Br]2+ maintained its intensity (20 %), being the base peak the 
one at 602.0 associated to [1C3-2Br]
2+. As expected, the peak 
at 336.5 associated to unreacted imidazole [C+H]+ considerably 
decreased (18%).
Moreover, when the 1:C molar ratios were ca. 1:2 and 1:3, the 
ESI-MS in positive ion mode after 48 h displayed the most 
intense peaks for the 1C3 clusters [1C3-3Br+2C]
3+ and [1C3-
3Br+C]3+, being the abundance of peaks from mono and 
bisimidazolium salts lower (ESI, Figure S4, Table S1). The ESI-
MS in positive ion mode after 697 h for the 1:3 molar ratio was 
simplified with the two most important peaks corresponding 
to [1C3-3Br]
3+ and [1C3-2Br]
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Figure 5 ESI-MS in positive ion mode obtained from an equimolar reaction mixture between tris(bromomethyl)benzene 1 and imidazole C after 48 h (top) and 697 h 
(bottom) of reaction. The initial concentration of both reactants was 13.8 mM. All the assigned peaks provided the correct isotopic pattern. The insets show the 
comparison of the calculated and observed isotopic patterns for the peaks at 375 and 602.
Some interesting differences were observed when the 
imidazole A was studied in the reaction with 1,3,5-
tris(bromomethyl)benzene. Imidazole A is identical to C, but 
lacks the amino acid moiety and, accordingly, the 
supramolecular potential associated to the peptidic bond in 
pseudopeptides.15,17 Reaction progress was monitored 
following the C2-H (imidazolium) and benzylic methylene 
signals for the tripodal compound 1A3 initially at 10.38 and 
5.54 ppm respectively. For the monosubstituted 1A and the 
disubstituted 1A2 the signals appeared initially at 11.17 and 
10.56 ppm respectively (imidazolium C2-H) and 5.68 and 5.63 
ppm (benzylic protons). The disappearance of the signals 
initially at 3.94 and 7.58 ppm for the N-CH2 and C2-H protons 
of imidazole A and at 4.45 ppm for the benzylic protons of 1 
were used to determine the conversion (ESI, Figure S5). These 
chemical shifts agreed with those for pure 1A3 or for the 
model compound 5 (ESI, Figure S6).
Figure 6a shows the kinetic profiles obtained when the 
reaction was run with an equimolar mixture of imidazole A and 
1 (13 mM). After 746 h at 25ºC, the conversion of the 
imidazole product was slightly higher than 90 %, but only 17 % 
of the consumed units were present in the tris(imidazolium) 
compound 1A3, with around 44 % and 28 % being incorporated 
into 1A2 and 1A species respectively. This behaviour clearly 
departs from the one observed for the pseudopeptidic 
imidazole C, revealing the importance of the amino acid 
derived fragment in the preferential formation of the tripodal 
structure 1C3, which must be associated to supramolecular 
interactions involving the pseudopeptidic moiety.
The experiment carried out using a fivefold excess of imidazole 
A over 1,3,5-tris(bromomethyl)benzene 1 provided the 
expected kinetic profile in the absence of supramolecular 
assistance (Figure 6b, see ESI Figure S7 for 1H NMR spectra) 
with 1A being the predominant species for the initial period, 
reaching a maximum yield of ca. 9 % at a reaction time of 40 h. 
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Afterwards, the yield of 1A starts to decrease while those for 
1A2 and 1A3 yields increase, being 1A2 the predominant 
species until 170 h of reaction (up to 27 % yield). Finally, after 
170 h, the amount of 1A2 starts also to decrease while the 
concentration of 1A3 steadily increases up to reach an 













































Figure 6 Kinetic profiles for the disappearance of A (blue) and 1 (black) and the 
formation of 1A (grey), 1A2 (yellow) and 1A3 (green) by reaction of 1 and A in 
CDCl3 at 25ºC following the C2-H protons for A, 1A, 1A2 and 1A3 and the benzylic 
protons for 1. a) using an equimolar ratio of 1 and imidazole A (13 mM). b) using 
a fivefold excess of A (18.6 mM) over 1 (3.6 mM).
m/z
































































Figure 7 ESI-MS in positive ion mode obtained from an equimolar reaction 
mixture between tris(bromomethyl)benzene 1 and imidazole A after 48 h 
(bottom) and 747 h (top) of reaction in CDCl3. The initial concentration of both 
reactants was 13 mM. All the assigned peaks provided the correct isotopic 
pattern. The insets show the comparison of the calculated and observed isotopic 
patterns for the peaks at 275 and 513. 
For the equimolar ratio of reagents and a reaction time of 48 
h, the ESI-MS in positive ion mode showed the peaks 
corresponding to the [1A-Br]+ (513.2, 100 %), [1A2-2Br]
2+ 
(335.4, 20 %) and [1A3-3Br]
3+ (275.4, 20 %) species (Figure 7). 
At higher reaction times (747 h), the peak at 237.4 associated 
to [A+H]+ decreases (from 80 % to 30 %), the peaks at 335.4 
and 275.4 m/z increase (40% and 28% respectively) and the 
peak at 513.2 m/z associated to [1A-Br]+ continue being the 
base peak (100%). When the reaction was run using an excess 
of A (3.9 mM in 1 and 19.9 mM in A) the peak for the 
unreacted imidazole was predominant at 48 h, while the one 
corresponding to [1A3-3Br]
3+ (275.4) became the base peak at 
longer reaction times (ESI, Figure S8, see also Table S2).
The presence of a long aliphatic tail is also an important 
structural feature of imidazole C. Thus, the reaction between 1 
and imidazole D having a methyl group instead of the dodecyl 
fragment was also studied by 1H NMR and ESI-MS to obtain 
information on its role on the overall process (ESI, Figures S9 
and S10). In this case, no significant differences were observed 
with respect to the use of imidazole C, revealing that the 
aliphatic chain does not play an important role for the 
observed preference towards the formation of 1C3 or 1D3. 
Attempts to analyse the reaction of 1 with imidazole B lacking 
both the amino acid derived fragment and the long tail were 
unsuccessful for the low solubility of the intermediates in 
CDCl3. Finally, the effect of changing the tris(halomethyl)arene 
was also studied. For the process involving imidazole C (14.8 
mM) and 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene 2 
(15.6 mM), the conversion was monitored by following the 1H 
NMR signals for the C2-H of the imidazole ring and the proton 
at the stereogenic carbon (initially at 7.81 and 4.24 ppm) in C 
along with the signal initially at 4.58 ppm for the benzylic 
protons of 2. The signals for the C2-H imidazolium proton of 
2C, 2C3 and 2C2, initially at 9.93, 9.80 and 9.40 ppm, were used 
to follow the formation of the different imidazolium species 
(ESI, Figure S11). The reaction was significantly faster than 
when using 1, but again the formation of the tripodal 
compound 2C3 was much favoured over that of 2C2 and 2C. In 
this case, 2C3 became the major species present in the 
reaction mixture after 0.5 h (ESI, Figure 12a). ESI-MS in positive 
ion mode also confirmed these data, with the peaks associated 
to the tripodal species [2C3-3Br]
3+ and [2C3-2Br]
2+ being the 
more intense even at short reaction times (100% and 62% 
respectively, ESI, Figure S13a). Similar results were obtained 
for other 2:C ratios (ESI, Figure S12c-d and S13c-d).
On the other hand, when the imidazole A (15.7 mM) and 2 
(13.8 mM) were used as starting materials, the reaction was 
again faster than with 1 but the formation of the 
monosubstituted and disubstituted imidazolium products 2A 
and 2A2 was favoured at all times over the formation of the 
tripodal compound. When a ca. 1:3 molar ratio (2:A) was used, 
2A and 2A2 were the predominant imidazolium species up to 
11 h of reaction and, later on, the concentration of these 
species decreased with the tripodal compound 2A3 becoming 
predominant (ESI, Figure S14). The formation of the different 
species was also confirmed by ESI-MS (ESI, Figure S15). Thus, 
the preferential formation of tripodal species is associated to 
the presence of the amide group in C and D. 
Some anions, and particularly bromide, are able to act as 
efficient catalysts in macrocyclization reactions involving SN2 
reactions and other processes of pseudopeptidic molecules.21 
The bromide anion can participate templating a proper 
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preorganization of the open chain precursor but also reducing 
the energy of the transition state through supramolecular 
interactions. Besides, the increase in the ionic strength of the 
medium has been reported to slightly increase the reaction 
rate in the synthesis of some dicationic imidazoliophanes 
through SN2 reactions.
13 When the reaction was carried out in 
the presence of NEt4Br (9 mM) employing imidazole C (16.6 
mM) and 1 (7.6 mM) the results obtained revealed that the 
main effect of the presence of bromide anion was a decrease 
in the overall conversion rate and in the formation of 1C3, 
although the tripodal compound was still the more abundant 
species (ESI, Figure S16).
Determination of kinetic constants. From the former 
experimental kinetic curves, a detailed kinetic analysis was 
carried out to determine the main kinetic parameters for each 
specific reaction. The fitting of the experimental data to a 
model considering a second order reaction for each step was 
carried out by means of the 2-&L6=% nonlinear 
least-squares algorithm,22 using the R and the RStudio 
software.23-25 Moreover, the Eyring equation, k = (kBT/h) 
(0LNO/RT),26 was employed to calculate the Gibbs free 
energy barrier. Table 1 summarizes the kinetic constants 
obtained following this approach. Calculated kinetic curves 
obtained from data in Table 1 show a good agreement with 
the experimental ones (ESI, Figure S17). Some deviations are 
observed for very long reaction times that can be associated to 
the difficulty in determining with enough accuracy the 
experimental values by 1H NMR for some of the species at 
these times and by the potential interference of the formation 
of unproductive supramolecular complexes between the 
tripodal species and the starting imidazole (e.g. C·1C3).
Data in Table 1 show that kinetic constants obtained for 1,3,5-
tris(bromomethyl)-2,4,6-trimethylbenzene 2 are significantly 
higher than those for 1,3,5-tris(bromomethyl)benzene 1. 
When the pseudopeptidic imidazole C is used, k1 is always 
smaller than k2 and k3, while k3 is always the smaller constant 
when imidazole A is used, highlighting the role of the amide 
moiety in the supramolecular assistance for the preferential 
formation of polytopic imidazolium systems. When analysing 
the absolute values for the constants, it is important to bear in 
mind that the concentration of the bromomethyl species has 
been used directly for the calculations. However, compounds 1 
or 2 contain three reactive sites, the monotopic species like 1C 
contain two reactive sites and the ditopic species like 1C2 
contain just one reactive site. Thus, a statistical correction 
provides the corresponding microconstants describing the 
intrinsic reactivity of the respective bromomethyl groups. This 
reveals that the intrinsic constants for the formation of 1C2 
and 1C3 are of the same order and both one order of 
magnitude higher than that for the formation of 1C. The 
intrinsic constant for the formation of 2C3 is almost two orders 
of magnitude higher than the one for the formation of 2C.













                                  
Macroscopic kinetic constantsb
1C3 0.46 ± 0.01 10.33 ± 1.04 4.43 ± 0.25 17.98 ± 0.01 16.13 ± 0.06 16.63 ± 0.03
1A3 0.99 ± 0.01 1.75 ± 0.04 0.72 ± 0.04 17.53 ± 0.01 17.18 ± 0.02 17.71± 0.03
2C3 9.36 ± 0.22 245.49 ±37.81 379.35 ±98.65 16.19 ± 0.01 14.24 ± 0.09 13.99 ± 0.14
2A3 11.81 ± 0.35 28.96 ± 1.65 9.04 ±  0.74 16.05 ± 0.02 15.51 ± 0.03 16.21 ± 0.05
Intrinsic kinetic constants
1C3 0.15 5.16 4.43
1A3 0.33 0.87 0.72
2C3 3.12 122.74 379.35
2A3 3.94 14.48 9.04
a All the experimental data, obtained using the different studied ratios between substrates, were used for the fitting. b k1, k2 and k3 correspond to the formation  of the 
monotopic, ditopic and tripodal compounds respectively.
Interaction studies. 1H NMR studies revealed significant 
chemical shift variations for the signals of the C*H, NH and C2-
H protons in the starting imidazoles C and D during the course 
of the reaction (Figure 2, see also ESI, Figure S9c). This 
suggests the existence of strong supramolecular interactions 
between the corresponding imidazole and the imidazolium 
species formed. This was corroborated by the ESI-MS of the 
reaction crudes with the observation of some clusters 
involving imidazolium species and the starting imidazole 
(Figure 5 and ESI, Figure S4). This should be in good agreement 
with the initial hypothesis regarding the formation of 
supramolecular complexes between C and 1C or 1C2 that could 
favour the formation of 1C2 and 1C3, justifying the 
predominant formation of tripodal species even when using a 
defect of C. To analyse this in more detail, imidazole C (15 mM) 
was titrated with the tripodal imidazolium salt 1C3, or the 
analogous mono- and bis-imidazolium model compounds 3 
and 4 using CDCl3 as solvent and the results followed by 
1H 
NMR (Figure 8 and ESI, Figure S18). The addition of increasing 
quantities of the imidazolium salts produced downfield shifts 
of the C2-H, amide NH and C*H proton signals of imidazole C, 
along with an upfield shift of the signal for the amide NH 
protons of the imidazolium salts. This agrees well with the 
presence of supramolecular imidazole-imidazolium species 
stabilized through hydrogen bonds involving the anion as the 
hydrogen bond acceptor and the amide N-H and the acidic 
hydrogen atoms of the imidazole / imidazolium ring as 
hydrogen bond donors. The key role played by the amide 
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groups and their relevance for the preferential formation of 
tripodal species is highlighted by the lack of any significant 
association when imidazole A, for which no preferential 





































Figure 8 1H NMR titration curves (500 MHz, CDCl3) following the imidazole C2-H 
(top) and the amide N-H (bottom) signals of C (15 mM) in the presence of 
increasing amounts of the monoimidazolium derivative (3, red squares), the 
bisimidazolium model compound (4, green triangles) or the tripodal derivative 
1C3 (blue circles).
Titration curves also suggest that the interaction of C is 
stronger with the mono- and bisimidazolium compounds than 
with 1C3. This is of interest as the preferential interaction of C 
with 1C and 1C2 can also contribute to promote the 
preferential formation of 1C3 in excellent yields even using a 
limited amount of C, avoiding the formation of significant 
amounts of C·1C3, and can be assigned to the presence of a 
strong intramolecular hydrogen bonding network in 1C3.
In this regard, it must be noted that NMR data suggest the 
presence of a rigid conformation in 1C3 with a strong non-
equivalence of the two hydrogen atoms of the benzylic groups. 
Again the amide group is essential for this behaviour as the 
NMR data for 1A3 are in agreement with less rigid 
conformations for this species (ESI, Figure S19). Rather 
surprisingly, a decrease in rigidity is observed for 2C3, as 
compared with 1C3, in spite of the presence of additional 
methyl groups in the aromatic fragment, which usually is 
accompanied by loss of conformational freedom in related 
systems.15a This is indicative of a stronger intramolecular 
hydrogen bonding network in 1C3 as confirmed by the higher 
chemical shifts detected for the acidic hydrogen atoms in 1C3 
(9.96 ppm for C2-H in 1C3 vs. 9.55 ppm for 2C3). Moreover, 
ROESY experiments and theoretical studies also supported a 
rigid arrangement of the three chains in 1C3 with the C2-H 
being close to one of the benzylic protons but not to the other 
(ESI, Figure S20) and the modelling showing a higher number 
of H-bonds linking the bromide anions and the imidazolium 
groups in 1C3 (ESI, Figure S21).
The role of the bromide anion in the formation of those 
supramolecular imidazole / imidazolium complexes also 
explains the observed reduction in reaction rates when using 
an excess of this anion. Thus, the addition of increasing 
quantities of bromide anion produced a downfield shift of the 
signals of the amide NH proton, the imidazole C2-H and the 
C*H for C while no significant changes were observed in the 
case of 1C3 (ESI, Figure S22). This supramolecular association 
between bromide and C would make less favourable the 
formation of the supramolecular complex of this starting 
material with the initially formed imidazolium species that 
promote a more rapid reaction. In the presence of excess 
bromide, imidazole / imidazolium clusters were not detected 
in ESI-MS experiments (ESI, Figure S16).
Such hydrogen bonding interactions are expected to be very 
sensible to polar protic solvents. Thus, the reaction between 
1,3,5-tris(bromomethyl)benzene 1 (9.0 mM) and imidazole C 
(13.3 mM) was also run in CD3OD. Following the 
1H NMR 
signals for C*H and C2-H of the imidazole C a significant 
decrease in reactivity was observed (e.g. at 498 h only 36% 
conversion of C occurred) (ESI, Figure S23a), H/D exchange did 
not allow a proper monitoring of C2-H signals in imidazolium 
species, but positive ion mode ESI-MS experiments after long 
reaction times (679 h, ESI, Figure S23b) revealed that ditopic 
and tritopic imidazolium compounds were very minor species, 
the mono imizadolium compound being the major formed 
species. This again confirms the key role of the supramolecular 
interactions involving hydrogen bonding between imidazolium 
intermediates and starting imidazoles.
Self-Sorting and Competitive Studies. Considering the 
observed differences between the pseudopeptidic imidazole C 
and imidazole A lacking the amino acid derived fragment, 
additional experiments were carried out to analyse the 
potential self-sorting when using 1,3,5-tris(bromomethyl) 
benzene 1 and an excess of an equimolar mixture of 
imidazoles A (13.7 mM) and C (13.9 mM) (2.5 equiv. each).27 
Figure 9 shows the ESI-MS in positive ion mode obtained after 
480 h of reaction. Although a full self-sorting is not observed 
the spectrum reveals the preferential incorporation of 
imidazole C into the polytopic imidazolium species. The 
unreacted imidazole A provides the base peak (237, [A+H]+), 
while the peak at 336.4 corresponding to [C+H]+ is very small 
(<5%). Mixed tripodal species [1AC2-3Br]
3+ (m/z: 341.6, 23%) 
and [1AC2-2Br]
2+ (552.4, 10%) are more important than those 
containing two units from A like [1A2C-3Br]
3+ (308.5, 10%). A 
relatively minor peak is also observed for the homotripodal 
species [1C3-2Br]
2+ at 602.1. The 1H NMR spectra also showed 
a preferential consumption of imidazole C (C/A molar ratio 
became 0.59 after 184 h) (ESI, Figure S24).
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Figure 9 ESI-MS in positive ion mode for the reaction between C (13.9 mM) and 
A (13.7 mM) with 1 (5.5 mM) after 480 h of reaction in CDCl3.
To assess the effect of the length of the aliphatic chain, 
additional competitive studies were run using a defect of 
1,3,5-tris(bromomethyl)benzene 1 and an equimolar mixture 
of C and D (3 equiv.). After 120 h of reaction, ESI-MS 
experiments showed the presence of homo- and heterotritopic 
species, but with a slight preference for the incorporation of 
imidazole D (ESI, Figure S25 and Table S3). This confirms that, 
in opposition to the amide fragment, the long aliphatic tail 
does not participate in the recognition process favouring the 
formation of the tripodal species. As a matter of fact, the 
presence of smaller aliphatic fragments seems to facilitate 
better this process.
Finally, competitive studies were run mixing 1,3,5-
tris(bromomethyl)benzene 1 (5 mM) and imidazoles C (3 
equiv.), D (3 equiv.) and A (3 equiv.) (ESI, Figure S26). In this 
case, after 120h, species containing the imidazole building 
block D seems to be favoured, with the most important 
species detected by ESI-MS in positive ion mode corresponding 
to [1D3-3Br]
3+ (220, 23%), [1CD2-3Br]
3+ (272, 25%), [1D3-2Br]
2+ 
(371, 3%) and [1CD2-2Br]
2+ (448, 3%). 
Computational studies. In order to get additional insights on 
the mechanisms involved, a computational study was carried 
out using Gaussian 1628 by means of the commonly used DFT 
functional (B3LYP)29 using the 6-311+G(d,p) basis set.30 In 
order to save computational time, imidazoles B and D lacking 
the long dodecyl aliphatic tail were selected as model 
compounds. This is reasonable taking into account that the 
change from dodecyl to methyl experimentally plays a minor 
role in the process. The evaluation of B and D still allows 
comparing the effect of the amide group. 
TS1 TS2 TS3
Figure 10 Structures of the calculated transition states obtained for the synthesis 
of 1D3.
For the pseudopeptidic compound D, the DFT study showed 
that formation of the monotopic derivative 1D presents a TS 
with a higher activation barrier than the one for the formation 
of the ditopic derivative 1D2, being this higher than that for the 
formation of the trisubstituted compound 1D3. The computed 
activation free enthalpies 0N4calc) were found to be 23.7, 13.5 
and 11.1 kcal/mol for 1D, 1D2 and 1D3, respectively (ESI, Table 
S4). For the imidazole B, the DFT study showed that the 
formation of the monotopic compound 1B occurs through a TS 
with a higher activation energy that the one required for the 
formation of 1B2; but this last barrier, however, was slightly 
lower than the one present in the formation of the tripodal 
derivative 1B3. The computed activation free enthalpies 
0N4calc) were in this case 27.0, 23.1 and 24.2 kcal mol
-1 for 1B, 
1B2 and 1B3, respectively (ESI, Table S4). When comparing the 
reaction of imidazole D with trisbromomethyl derivatives 1 
and 2, the computed activation barriers for the formation of 
species derived from 2 were always slightly lower that the 
ones computed for species derived from 1. Thus, the methyl 
substitution on the central aromatic ring accelerates the SN2 
reaction as observed experimentally (ESI, Table S4). All the 
reactions were exergonic with free reaction energy values 
ranging from -5 to -15 kcal mol-1.
Figure 10 shows the three consecutive transition states 
calculated for the reaction between 1 and D. As can be 
observed for [TS2]R and [TS3]
R, both TSs display intramolecular 
hydrogen bonds linking the imidazolium and the imidazole 
fragments involved in the reaction through a bromide anion. In 
both cases the hydrogen atom at the C2 position of the 
imidazolium ring participates in the hydrogen bond network, 
highlighting the supramolecular potential of imidazolium 
subunits. For [TS2]R the imidazolium fragment displays two 
hydrogen bonds to the bromide involving the amide N-H and 
the C2-H of the imidazolium ring. The smaller distance 
calculated for NH···Br- suggests that this hydrogen bond is 
stronger than the one with the C2-H as should correspond with 
its higher acidity.  For [TS3]R the two imidazolium subunits are 
hydrogen bonded to one bromide anion. One of them 
participates with the amide N-H and the C2-H moieties, while 
the second one only participates with the amide N-H fragment. 
Thus, the C2-H of this imidazolium group is hydrogen bonded 
with a second bromide displaying a hydrogen bond with the 
amide NH of the reacting imidazole.   Interestingly, a strong 
hydrogen bonding of the imidazole units, significantly 
favouring the formation of the polytopic derivatives, takes 
place when the amide group is present. Thus, computational 
results are in excellent agreement with the experimental ones, 
and support the presence of supramolecular interactions, even 
at the TS level, of the formed imidazolium groups with the 
imidazole nucleophiles, particularly relevant for 
pseudopeptidic systems. 
Conclusions
Supramolecular interactions associated to the presence of the 
peptidic bond are essential in many natural systems but also in 
pseudopeptidic receptors, and the results presented here 
show that they are also able to strongly assist the synthesis of 
polytopic pseudopeptidic imidazolium compounds. The 
experimental data presented, in good agreement with 
computational calculations, reveal that in the considered 
trisimidazolium compounds the introduction of the first 
imidazolium fragments facilitates the second functionalization 
by establishing supramolecular interactions with the imidazole 




































































































































Journal Name  ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 9
Please do not adjust margins
Please do not adjust margins
acting as the nucleophilic reagent. Once the ditopic system is 
formed, similar supramolecular interactions favour the 
formation of the tripodal imidazolium system. According to 
computational calculations, such supramolecular interactions 
are also present at the corresponding TSs ([TS2]R and [TS3]
R). 
The imidazole/imidazolium groups considered contain three 
different structural elements of interest for supramolecular 
interactions: the imidazole/imidazolium group itself, the amide 
group associated to the amino acid involved, and a long 
aliphatic tail (dodecyl group). However, the study of similar 
processes involving other imidazole derivatives lacking either 
the amide group or the long aliphatic tail has demonstrated 
that the combination of the imidazole/imidazolium fragments 
containing an amide group is playing the key role in those 
supramolecular interactions, while the length of the aliphatic 
tail does not provide a significant contribution. The importance 
of this supramolecular assistance is highlighted by the fact that 
in the case of pseudopeptidic imidazole reagents, the tripodal 
imidazolium compound is always obtained as the very major 
product even when a defect of imidazole (e.g. 1/3 of the 
stoichiometric amount) is used for the reaction. This behaviour 
is reminiscent of the one found in autocatalytic and self-
replicating systems.
Experimental
General: All reagents were purchased from commercial 
suppliers and used as received. The NMR spectroscopic 
experiments were carried out at the field reported, at 25 ºC 
and using trimethylsilane as the internal standard. Microwave 
reactions were carried out using a Discover System Model 
908010 from CEM Corporation using custom-made high purity 
quarts vials (capacity 10 mL). ESI-MS experiments were 
recorded on a Q-TOF Premier mass spectrometer with an 
orthogonal Z-spray electrospray interface (Micromass, 
Manchester, UK) by electrospray in positive or negative mode.
Synthesis of 1A3: Compound A (0.308 g, 1.27 mmol, 3.3 equiv.) 
and 1,3,5-tris(bromomethyl)benzene (0.141 g, 0.39 mmol, 1 
equiv.) were dissolved in acetonitrile (3 mL) in a microwave 
tube and heated in a microwave instrument at 150 ºC (120 W) 
for 1 h. The precipitate obtained was filtered, washed with 
cold ethyl acetate and vacuum dried. The product was a beige 
solid (0.38 g, 93%). M.p. (DSC): 178.2 ºC. BWD D
25 = -2.51 (c = 
0.021, CH3OH). IR (ATR): 3419, 3083, 2919, 2850, 1553, 1467 
cm1. 1H NMR (300 MHz, CDCl3) YM 10.44 (s, 3H), 8.65 (s, 3H), 
8.63 (s, 3H), 7.06 (s, 3H), 5.54 (s, 6H), 4.22 (q, J = 7.6, 6.2 Hz, 
6H), 1.25 (s, 6H), 1.40-1.17 (m, 54H), 0.95  0.79 (m, 9H). 13C 
NMR (101 MHz, CDCl3): YM 136.5, 135.5, 132.0, 124.5, 121.2, 
52.1, 50.3, 31.9, 30.1, 29.6, 29.6, 29.5, 29.4, 29.3, 29.0, 26.3, 
22.6, 14.1 ppm. MS (ESI+): m/z (%) = 275 (100) [C54H93N6]
3+. 
Calculated for C54H93N6Br3·3.5 H2O: C 57.4, H 8.9, N 7.4; found 
C 57.4, H 8.4, N 7.2.
Synthesis of 2A3: Compound A (0.100 g, 0.42 mmol, 3.3 equiv.) 
and 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene (0.057 g, 
0.13 mmol, 1 equiv.) were dissolved in chloroform (5 mL) and 
stirred in a round bottom flask (25 mL) for 5 days at rt. The 
reaction gave a yellow solid product (0.13 g, 94%). M.p. (DSC): 
297.5 ºC. BWD D
25 = -0.45 (c = 0.021, CH3OH). IR (ATR): 3432, 
3067, 2921, 2852, 1559, 1465 cm1. 1H NMR (400 MHz, CDCl3) 
YM 10.00 (s, 3H), 8.43 (s, 3H), 7.28 (s, 3H), 5.80 (s, 6H), 4.31 (t, J 
= 7.4 Hz, 6H), 2.34 (s, 9H), 2.20 (s, 6H), 1.41-1.13 (m, 54H), 0.87 
(t, J= 6.8 Hz, 9H). 13C NMR (101 MHz, CDCl3): YM 142.0, 135.5, 
136.0, 129.0, 124.1, 121.7, 50.0, 49.3, 31.9, 30.5, 29.6, 29.6, 
29.4, 29.3, 29.1, 26.3, 22.7, 17.7 14.1 ppm. MS (ESI+): m/z (%) = 
290 (100) [C57H99N6]
3+, 474 (31) [C57H99N6Br]
2+. Calculated for 
C57H99N6Br3·4.5 H2O: C 57.6, H 9.2, N 7.1; found C 57.7, H 8.6, 
N 6.6.
Synthesis of 1C3: Compound C (0.299 g, 0.89 mmol, 3.3 equiv.) 
and 1,3,5-tris(bromomethyl)benzene (0.079 g, 0.22 mmol, 1 
equiv.) were dissolved in acetonitrile (2.23 mL) in a microwave 
tube and heated in a microwave instrument at 150 ºC (120 W) 
for 1 h. The solvent was evaporated, and the residue washed 
with cold ethyl acetate and vacuum dried. The product was a 
beige solid (0.33 g, 97%). M.p. (DSC): 184.8 ºC. BWD D
25 = 13.77 
(c = 0.021, CH3OH). IR (ATR): 3227, 3063, 2921, 2952, 1679 cm

1. 1H NMR (400 MHz, CDCl3) YM 9.97 (s, 3H), 8.37 (d, J = 19.4 Hz, 
6H), 8.10 (s, 3H), 7.39 (s, 3H), 5.50 (dd, J = 185.7, 14.1 Hz, 6H), 
5.02 (d, J = 10.7 Hz, 3H), 3.30 (m, 3H), 2.91  2.29 (dm, 6H), 
1.59  1.37 (m, 6H), 1.35  1.08 (m, 54H), 1.01 (dd, J = 12.0 Hz, 
9H), 0.81 (t, J = 6.9 Hz, 9H), 0.70 (dd, J = 6.6 Hz, 9H). 13C NMR 
(126 MHz, CDCl3): YM 163.6, 133.3, 132.8, 129.1, 121.7, 116.9, 
65.9, 49.6, 37.3, 29.3, 28.4, 27.0, 26.7, 26.5, 24.4, 20.1, 16.2, 
15.7, 11.5 ppm. MS (ESI+): m/z (%) = 374.5 (100) 
[C69H120N9O3]
3+, 602.0 (45) [C69H120N9O3Br]
2+.Calculated for 
C69H120N9O3Br3·H2O: C 60.0, H 8.9, N 9.2; found C 59.8, H 8.4, N 
9.5.
Synthesis of 2C3: Compound C (0.100 g, 0.30 mmol, 3.3 equiv.) 
and 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene (0.040 g, 
0.10 mmol, 1 equiv.) were dissolved in dichloromethane (2.23 
mL) in a microwave tube and heated in a microwave 
instrument at 150 ºC (120 W) for 1 h. The solvent was 
evaporated, and the residue washed with dimethyl ether and 
vacuum dried. The product was a beige solid (0.099 g, 94%). 
M.p. (DSC): 153.2 ºC. BWD D
25 = -45.89 (c = 0.021, CH3OH). IR 
(ATR): 3240, 3062, 2923, 2853, 1678 cm1. 1H NMR (400 MHz, 
CDCl3) YM 9.60 (s, 3H), 8.08 (s, 3H), 7.94 (s, 3H), 7.73 (d, J=20.6 
Hz, 3H), 6.43-5.20 (m, 6H), 5.38 (d, J = 10.2 Hz, 3H), 3.33 (m, 
3H), 3.04 (m, 3H), 2.39 (s, 6H), 2.37 (s, 9H), 1.52 (s, 3H), 1.23 (s, 
54H), 1.06 (dd, J = 25.2, 6.5 Hz, 9H), 0.87 (t, J = 6.9 Hz, 9H), 
0.74 (d, J = 6.1 Hz, 9H). 13C NMR (101 MHz, CDCl3): YM 166.8, 
142.0, 135.7, 129.0, 121.6, 67.6, 49.4, 39.9, 31.9, 29.6, 29.2, 
27.0, 22.7, 18.8, 18.3, 17.5, 14.1 ppm. MS (ESI+): m/z (%) = 
623.0 (100) [C72H125N9O3Br]
2+, 388.6 (91) [C72H126N9O3]
3+. 
Calculated for C72H126N9O3Br3·H2O: C 60.8, H 9.1, N 8.9; found 
C 60.5, H 9.2, N 8.9. 
Synthesis of 1D3: Compound D (0.100 g, 0.55 mmol, 3.3 equiv.) 
and 1,3,5-tris(bromomethyl)benzene (0.068 g, 0.19 mmol, 1 
equiv.) were dissolved in chloroform (5 mL) and stirred in a 
round bottom flask (25 mL) for 5 days at rt. The solvent was 
evaporated, and the residue washed with dimethyl ether and 
vacuum dried. The product was a beige solid (0.053 g, 89%). 
BWD D
25 = 38.75 (c = 0.021, CH3OH). IR (ATR): 3397, 3077, 2967, 
1673, 1550 cm1. 1H NMR (400 MHz, CDCl3) YM 10.01 (s, 3H), 
8.43 (s, 3H), 8.41 (s, 3H), 8.19 (s, 3H), 7.48 (s, 3H), 5.57 (dd, 
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J=122.3, 14.1 Hz, 6H), 5.08 (d, J=10.8 Hz, 3H), 2.72 (d, J = 4.6 
Hz, 9H), 2.40 (m, 3H) 0.92 (dd, J = 110.8, 6.6 Hz, 18H). 13C NMR 
(101 MHz, CDCl3): YM 166.9, 135.8, 135.4, 131.8, 124.3, 119.6, 
74.5, 68.4, 52.2, 30.8, 26.2, 18.8, 18.3 ppm. MS (ESI+): m/z (%) 
= 220 (100) [C36H54N9O3]
3+. Calculated for C36H54N9O3Br3: C 
62.0, H 8.4, N 18.1; found C 62.1, H 8.3, N 18.0. 
Synthesis of 2D3: Compound D (0.100 g, 0.55 mmol, 3.3 equiv.) 
and 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene (0.075 g, 
0.19 mmol, 1 equiv.) were dissolved in chloroform (5 mL) and 
stirred in a round bottom flask (25 mL) for 5 days at rt. The 
solvent was evaporated, and the residue washed with 
dimethyl ether and vacuum dried. The product was a beige 
solid (0.133 g, 84%). M.p. (DSC): 362.7 ºC. BWD D
25 = 2.62 (c = 
0.021, CH3OH). IR (ATR): 3395, 3232, 3073, 2967, 1673, 1546 
cm1. 1H NMR (400 MHz, CDCl3) YM 9.54 (s, 3H), 8.16 (s, 3H), 
7.84 (s, 3H), 7.72 (s, 3H), 5.66 (d, J=19.7 Hz, 6H), 5.26 (d, J=10.1 
Hz, 3H), 2.70 (d, J=4.2 Hz, 9H), 2.45 (s, 9H), 2.40 (s, 3H), 0.96 (d, 
J=6.5 Hz, 9H), 0.68 (d, J=6.5 Hz, 9H). 13C NMR (101 MHz, CDCl3): 
YM 167.4, 142.0, 135.7, 129.07, 122.8, 121.7, 67.7, 49.5, 31.4, 
26.3, 18.8, 18.3, 17.6 ppm. MS (ESI+): m/z (%) = 234 (100) 
[C39H60N9O3]
3+. Calculated for C39H60N9O3Br3·8H2O: C 43.1, H 
7.1, N 11.6; found C 43.4, H 6.5, N 11.0.
Computational details: The calculations were performed with 
the Gaussian 16 program using the widely used DFT method 
based on Beckes GGA exchange functional B3LYP with 
standard 6-311+G(d,p) basis set. The stationary points were 
fully characterized by means of harmonic vibrational frequency 
analysis. For all of the transition structures, the normal mode 
related to the imaginary frequency corresponds to the nuclear 
motion along the reaction coordinates under study. 
Additionally, we carried out intrinsic reaction coordinate  
calculations (IRC) to verify that the transition structures were 
connected with reactants and products.
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